Stephen K Doberstein Dicerna Pharmaceuticals Inc (DRNA) insider trading activity

Stephen K Doberstein is Director of Dicerna Pharmaceuticals Inc. Currently has a direct ownership of 0 shares of DRNA, which is worth approximately $0. The most recent transaction as insider was on Dec 28, 2021, when has been sold 3,333 shares (Common Stock) at a price of $38.25 per share, resulting in proceeds of $127,487. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Stephen K Doberstein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Dec 28 2021	SELL Disposition due to a tender of shares in a change of control transaction	$127,487 $38.25 p/Share	3,333 Reduced 100.0%	0 Common Stock
Jun 03 2021	BUY Exercise of conversion of derivative security	-	3,333 Added 50.0%	3,333 Common Stock

Also insider at

FBRX

Forte Biosciences, Inc. Healthcare

SKD